Chemical formula: C₂₄H₃₁ClO₇ Molecular mass: 394.889 g/mol
Loteprednol etabonate is a new class of corticosteroid with potent antiinflammatory activity designed to be active at the site of action. Its antiinflammatory activity is similar to the most powerful steroid used in ophthalmology but with less intraocular pressure.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| S01BA14 | Loteprednol | S Sensory organs → S01 Ophthalmologicals → S01B Antiinflammatory agents → S01BA Corticosteroids, plain |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| ALREX Ophthalmic suspension | FDA, National Drug Code (US) | MPI, US: SPL/Old | |
| LOTEMAX Eye-drops, suspension | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Loteprednol is an active ingredient of these brands:
United States (US)Austria (AT)
Brazil (BR)Cyprus (CY)
Ecuador (EC)
Estonia (EE)
Ireland (IE)
Lithuania (LT)
Mexico (MX)
Poland (PL)
Singapore (SG)Tunisia (TN)
Turkey (TR)United Kingdom (UK)
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
